VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,000 | +77.8% | 1,096 | +188.4% | 0.01% | +100.0% |
| Q3 2016 | $9,000 | -75.7% | 380 | +5.3% | 0.00% | -62.5% |
| Q4 2015 | $37,000 | -99.5% | 361 | -99.1% | 0.01% | -99.6% |
| Q3 2015 | $6,800,000 | -18.5% | 38,008 | +1.0% | 2.24% | -7.3% |
| Q2 2015 | $8,342,000 | +0.3% | 37,619 | -10.8% | 2.41% | -3.0% |
| Q1 2015 | $8,314,000 | +14.6% | 42,155 | -16.8% | 2.48% | +37.5% |
| Q4 2014 | $7,253,000 | -7.5% | 50,667 | -15.3% | 1.81% | +7.0% |
| Q3 2014 | $7,840,000 | +211.7% | 59,824 | +200.8% | 1.69% | +206.9% |
| Q2 2014 | $2,515,000 | +93.0% | 19,891 | +100.9% | 0.55% | +91.0% |
| Q1 2014 | $1,303,000 | -86.9% | 9,900 | -88.3% | 0.29% | -86.3% |
| Q4 2013 | $9,967,000 | +30.2% | 84,964 | +15.6% | 2.10% | +31.5% |
| Q3 2013 | $7,656,000 | +15.9% | 73,491 | -4.1% | 1.60% | +13.7% |
| Q2 2013 | $6,607,000 | – | 76,645 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |